Category: duplication retractions

Acid studies burned by duplication test in corrosion papers

ldis20.v034.i07.coverPetroleum engineers in Iran have lost a pair of papers in the Journal of Dispersion Science and Technology for duplication and misuse of data.

The authors, whose various and varying affiliations include the National Iranian Oil Company, the Iranian Offshore Oil Company and Karaj Azad University, appear to have plagiarized not once, but twice: Two 2014 papers are both “substantially similar” to a 2013 paper, all published in the same journal. Which says plenty about both parties, we think.

What’s more, both retracted papers lifted data from a 2013 article in another journal, Industrial & Engineering Chemistry Research, “without proper citation.”    Continue reading Acid studies burned by duplication test in corrosion papers

Journal runs retraction, editorial over duplicate submission of pathology paper

WebCurrentCoverThe International Journal of Occupational and Environmental Medicine has taken a hard stance against overlapping publications in a recent retraction note and editorial.

Shortly after publishing a paper about the glycosylation patterns of endothelial cells in usual interstitial pneumonia, IJOEM editors discovered that it had been accepted by the Scholarly Journal of Biological Science two weeks before it was submitted to the IJOEM.

According to two authors we reached via email, Abolfazl Barkhordari and Carolyn Jones, SJBS requested a $300 publication fee, which Barkhordari (a corresponding author) was unable to pay due to economic sanctions against Iran, where he is based.

Barkhordari provided us with an email from the SJBS stating that the paper would not be published until $300 was transferred into a Nigerian bank account. The Nigeria-based publisher, Scholarly Journals, is on Jeffrey Beall’s list of predatory open access publishers.

Barkhordari and Jones assumed the SJBS was a dead end, so submitted the paper elsewhere.

Continue reading Journal runs retraction, editorial over duplicate submission of pathology paper

Rebirth of ovary article prompts retraction from OB lit

ejoglogoThe European Journal of Obstetrics & Gynecology and Reproductive Biology has retracted a 2014 paper on polycystic ovary syndrome for self-plagiarism.

In the notice, the journal states that “significant portions” of the findings in “Association of anti-Mullerian hormone and small-dense low-density lipoprotein cholesterol with hepatosteatosis in young lean women with and without polycystic ovary syndrome” already appeared in another paper. Three authors appear in both publications, all based at the University of Ufuk (don’t think too hard about that name) in Ankara, Turkey. Continue reading Rebirth of ovary article prompts retraction from OB lit

First cut is the deepest: paper on incisional hernia sliced for duplication

jamcolsurgeonsThe authors of a 2014 paper in the Journal of the American College of Surgeons about incisional hernia have lost their article for being a duplicate submission.

The paper, “Impact on Quality of Life of Using an Onlay Mesh to Prevent Incisional Hernia in Midline Laparotomy: A Randomized Clinical Trial,” came from a group at the Parc Tauli University Hospital, part of the Universitat Autònoma de Barcelona, in Spain.

By duplicating another paper, the authors (three of which appear to be listed on both papers) committed “a severe abuse of the scientific publishing system,” according to the retraction notice: Continue reading First cut is the deepest: paper on incisional hernia sliced for duplication

Publisher and uni go head to head over disputed images in diabetes papers

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

The State University of Campinas University of Campinas and the American Diabetes Association disagree strongly over how to handle disputed images from faculty member Mario Saad, who is suing the ADA to prevent retraction of his papers.

While the State University of Campinas University of Campinas (Unicamp) acknowledges that 2 of Saad’s papers contain “mistakes”, it concluded there was “not an intention in the actions of the authors,” and the mistakes did not have a negative impact on the scientific community. Ultimately: “the studies published have their own strength, are healthy and were not artificially strengthened by the incorrect images.”

In response, however, Saad’s lawsuit says the ADA asked the school to reinvestigate the articles, and refused to accept any papers from Unicamp faculty in any ADA journals until the issues are resolved.

The ADA has issued four expressions of concern in Saad’s research published in its flagship journal, Diabetes. Saad’s lawsuit aims to prevent the journal from retracting those papers, and asks for monetary compensation.

Retraction Watch has obtained a report of the investigation by Unicamp and Saad’s lawsuit. You can read the full lawsuit here, and the investigation report here.

Here is an excerpt from the Unicamp’s findings: Continue reading Publisher and uni go head to head over disputed images in diabetes papers

Diabetes researcher sues journal to prevent retractions of papers cited more than 600 times

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

Mario A. Saad, who last year retracted a paper for plagiarism, is now suing the American Diabetes Association over four expressions of concern in its flagship journal, Diabetes.

As reported in the Boston Business Journal, Saad’s lawsuit claims that his institution, the State University of Campinas, investigated two articles at the journal’s behest. The American Diabetes Association was unhappy with the results, and asked the school to reopen the investigation, including two additional papers.

Saad is suing to prevent the journal from retracting the papers, in addition to monetary compensation.

Continue reading Diabetes researcher sues journal to prevent retractions of papers cited more than 600 times

Heart study bleeds into three papers, one retracted and one withdrawn

janWith the increasingly hectic pace of modern life, everybody is always on the look out for time-saving tricks and tips.

Scientists at the National University of Singapore and the Hong Kong Polytechnic University certainly found one, but we really can’t recommend it: doing one randomized controlled trial (RCT) with several outcomes, and publishing them as three separate 2014 papers with “considerable overlap.”

So far, one paper has been retracted, and another withdrawn.

Continue reading Heart study bleeds into three papers, one retracted and one withdrawn

Fourth retraction appears for cancer researcher Anil Jaiswal

cancer research 1113The hits keep coming for University of Maryland researcher Anil Jaiswal.

The latest retraction for the cell biologist is in Cancer Research, for a 2007 paper about ways in which the cell tries to protect the tumor suppressor p53. Like the first Jaiswal retraction we covered, the latest notice specifically taps figure duplication as the cause of death, “as a result of an error.” The other two retractions gave no explanation for the withdrawal.

Here’s the notice: Continue reading Fourth retraction appears for cancer researcher Anil Jaiswal

“Genuine error” sees expression of concern for vision loss paper

elsevierA duplicated figure has resulted in an expression of concern for a paper in the American Journal of Pathology on a treatment for ocular neovascularization, which causes vision loss.

According to the notice, the corresponding author, David Shima, now at University College London, brought his concern to the journal. He called it a “genuine error” and stated that all the findings had been reproduced.

Unfortunately, Shima claimed the original data are missing, because the institution that owned the information — Eyetech Research Center — has “since gone through several acquisitions.”

Ocular neovascularization occurs when growth signals in the eye stimulate the creation of many new blood vessels. Over time these blood vessels break, causing bleeding and scarring that limits vision. This is called “wet” macular degeneration.

The scientists found that giving patients drugs to limit two different growth factors at the same time is more effective than one at stopping the progression of AMD. This combination method is in stage three clinical trials, though with different drugs than the authors used here.

The paper, published in 2006, has been cited 130 times, according to Thomson Scientific’s Web of Knowledge. Here’s the EoC for “Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization”:

Continue reading “Genuine error” sees expression of concern for vision loss paper

Serial plagiarist loses 13 papers

NeoheliconAccusations of plagiarism spanning at least 14 years have finally caught up with Richard Lawrence Etienne Barnett, who has had 13 papers retracted from a journal he had guest edited.

The dean of the for-profit University of Atlanta has been accused of copying his own and others’ work a number of times, as we wrote in November.

Here’s the notice from Neohelicon editor Péter Hajdu: Continue reading Serial plagiarist loses 13 papers